Info
Insider Trading

Sean Smith - Insider Trading & Ownership

Location: C/O Neoleukin Therapeutics, Inc., 188 E. Blaine Street, Suite 450, Seattle, WA
Summary: The estimated net worth of Sean Smith is at least $15K dollars as of August 14, 2023. Sean Smith is the Interim CFO, Prin Acct Off of Neoleukin Therapeutics, Inc. and owns shares of Neurogene Inc. (NGNE) stock worth about $15K.
Signature: /s/ Sean Smith
All Insider Reports: All Insider Reports

Notify me when Sean Smith files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Sean Smith

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
NGNE	Neurogene Inc.	Interim CFO, Prin Acct Off	$15K			Aug 10, 2023

Insider Transactions Reported by Sean Smith:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.